Biolytx Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $257K

  • Investors
  • 4

Biolytx Pharmaceuticals General Information

Description

Developer of peptide-based antibiotics designed to treat serious pathogens with no current therapeutic options. The company's antibiotics include a suite of antimicrobial drug candidates for the treatment including those resistant to current antibiotics, enabling healthcare professionals to cure patients.

Contact Information

Website
www.biolytx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 800 Research Parkway
  • Suite 334
  • Oklahoma City, OK 73104
  • United States
+1 (405)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 800 Research Parkway
  • Suite 334
  • Oklahoma City, OK 73104
  • United States
+1 (405)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolytx Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 30-Sep-2021 $257K Completed Pre-Clinical Trials
5. Later Stage VC 27-Nov-2019 Completed Pre-Clinical Trials
4. Accelerator/Incubator 16-Mar-2017 Completed Pre-Clinical Trials
3. Seed Round 16-Oct-2015 Completed Pre-Clinical Trials
2. Grant 10-Nov-2010 $1.8M $100K Completed Pre-Clinical Trials
1. Seed Round 23-Apr-2007 $100K $100K Completed Pre-Clinical Trials
To view Biolytx Pharmaceuticals’s complete valuation and funding history, request access »

Biolytx Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolytx Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Crawley Ventures Venture Capital Minority
The EDGE endowment policy board Other
i2E Not-For-Profit Venture Capital Minority
To view Biolytx Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Biolytx Pharmaceuticals FAQs

  • When was Biolytx Pharmaceuticals founded?

    Biolytx Pharmaceuticals was founded in 2005.

  • Where is Biolytx Pharmaceuticals headquartered?

    Biolytx Pharmaceuticals is headquartered in Oklahoma City, OK.

  • What is the size of Biolytx Pharmaceuticals?

    Biolytx Pharmaceuticals has 2 total employees.

  • What industry is Biolytx Pharmaceuticals in?

    Biolytx Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Biolytx Pharmaceuticals a private or public company?

    Biolytx Pharmaceuticals is a Private company.

  • What is Biolytx Pharmaceuticals’s current revenue?

    The current revenue for Biolytx Pharmaceuticals is .

  • How much funding has Biolytx Pharmaceuticals raised over time?

    Biolytx Pharmaceuticals has raised $1.86M.

  • Who are Biolytx Pharmaceuticals’s investors?

    National Institutes of Health, Crawley Ventures, The EDGE endowment policy board, and i2E have invested in Biolytx Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »